Skip to main content

Table 1 Associations between clinical and histopathological features and expression of vimentin.

From: Does vimentin help to delineate the so-called 'basal type breast cancer'?

Feature Vimentin-negative
N = 141
Vimentin-positive
N = 38
p value
Age (mean) 58.09 51.79 0.024
Tumour size    0.294
T1 43 15  
T2-4 98 23  
Nodal status    0.718
Negative 64 16  
Positive 77 22  
Grading    <0.001
G1-2 90 10  
G3 51 28  
ER    <0.001
Negative 70 31  
Positive 71 7  
PgR    <0.001
Negative 64 31  
Positive 77 7  
CK5/6    <0.001
Negative 109 8  
Positive 32 30  
CK14    <0.001
Negative 134 21  
Positive 7 17  
CK17    <0.001
Negative 118 16  
Positive 23 22  
CK5/6 or 14 o r17    <0.001
Negative 105 8  
Positive 36 30  
HER2    0.004
Negative 110 37  
Positive 31 1  
Triple negativity    <.001
Yes 25 29  
No 116 9  
P-cadherin    0.110
Negative 61 11  
Positive 80 27  
Cyclin E    0.058
Negative 65 11  
Positive 76 27  
Ki-67 expression, % (mean) 9.09 11.34 0.152
  1. The second and third columns contain numbers of patients, age and Ki-67 expression excepted.